Description
Added on the 17/03/2016 19:06:26 - Copyright : Reuters EN
Scientists in Sweden and the UK are conducting the first clinical trial injecting stem cells into babies still in the womb to help lessen the symptoms of Brittle Bone Disease.
The common parasite Toxoplasma gondii is spread to people through undercooked pork and occasionally domestic cats. Chronic T. gondii infections are linked to an increased risk of schizophrenia, lowered cognition, and behavioral changes like more risk-taking and aggression. Now, scientists say the parasite might have more insidious health effects than previously suspected. Gizmodo reports new research suggests a link between Toxoplasma gondii infection and an increased risk of gliomas, the most common form of brain cancer. The US sees 24,000 new cases of brain cancer annually, while 11% of Americans over age six carry T. gondii--upwards of 30 million people. So even if the connection is real, the chances of getting brain cancer as a result of chronic T. gondii infection are very low on an individual level.
Choosing safe and effective flea prevention for your cat or kitten can be tricky. Fleas can pose serious risks to your feline friend's health, but with treatment, you can keep your pet safe and healthy. Effective flea control products for cats are available as topical preventives, oral preventives, and collars. According to Business Insider, the best prescription topical flea treatment for cats is Revolution Plus Topical Solution. The product is a monthly preventive that protects against fleas in all life stages, is easy to apply, and completely waterproof. Before starting your cat on any flea treatment or prevention, you should consult your veterinarian.
There has been a new medical breakthrough in the fight against myeloid leukemia or AML. A new drug for AML improves overall survival in people with the deadly blood cancer by up to 10 months. That's according to the results of a Phase 3 clinical trial published Thursday by the New England Journal of Medicine. The study conducted at 148 hospitals in 23 countries. The drug is called CC-486. UPI health reports the CC-486 improved survival in patients age 55 and older. "It is very exciting to think that, by taking a tablet that is relatively well-tolerated, we can help reduce relapse risk and improve survival," study co-author Dr. Andrew Wei said in a press release.
|
Support : Technical 
- Content 
- Editors 
